EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AHR Deficiency Exacerbates Hepatic Cholesterol Accumulation via Inhibiting Bile Acid Synthesis in MAFLD Rats

Junjiu Xu, Pengwei Liu, Yuling Wu, Hongxiu He, Dandan Hu, Jianhua Sun, Jing Chen, Ying Tian iD, Likun Gong iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Junjiu Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210046, China. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Cholesterol, Liver, Bile Acids and Salts. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: High-level Innovative Research Institute of Department of Science and Technology of Guangdong Province, High-level Innovative Research Institute of the Department of Science and Technology of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic-dysfunction-associated fatty liver disease (MAFLD) is a chronic liver disease characterized by abnormal lipid metabolism. The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor involved in regulating multiple physiological processes. Recent studies have demonstrated that AHR exerts a multifaceted regulatory role in liver diseases by integrating metabolic and immune signaling pathways; however, the specific role of AHR in MAFLD is not clear. In our work, a rat model of MAFLD was established by feeding wild-type (WT) and AHR knockout (AHR−/−) rats with a high-fat, high-fructose, and high-cholesterol diet (HFHFrHCD) for 10 weeks, and then the liver injury markers, lipid-related biochemical indices and liver histopathology were examined to elucidate the effect of AHR on MAFLD progression. We discovered that AHR deficiency can elevate plasma transaminase levels, increase hepatic triglyceride (TG) and total cholesterol (TC), and exacerbate insulin resistance (IR) under an overnutrition environment. Subsequently, liver transcriptome and RT-qPCR were performed to investigate the underlying mechanism, which revealed that the hepatic bile acid synthesis was inhibited because of lower Cytochrome P450 Family 7 Subfamily A Member 1 (CYP7A1) expression in the liver when AHR was knockout. Additionally, intestinal flora dysbiosis occurred in AHR−/− rats fed with HFHFrHCD, which might also contribute to the hepatic cholesterol accumulation. Taken together, our results suggested that AHR might play an important role in regulating cholesterol metabolism by inhibiting bile acid synthesis and breaking the steady state of the gut microbiota during the MAFLD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Aryl HydrocarbonCholesterolLiverBile Acids and SaltsFatty LiverBasic Helix-Loop-Helix ProteinsAnimalsRatsMaleDisease Models, AnimalCholesterol 7-alpha-HydroxylaseGastrointestinal MicrobiomeLipid MetabolismDiet, High-FatInsulin ResistanceRats, Sprague-DawleyTriglycerides

Stichwörter der Autor:innen

AHRMAFLDbile acidcholesterolgut microbiota

Substanzen

Receptors, Aryl HydrocarbonCholesterolBile Acids and SaltsAhr protein, ratCholesterol 7-alpha-HydroxylaseBasic Helix-Loop-Helix ProteinsCYP7A1 protein, ratTriglycerides

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210046, China.
  • Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizhou Medical University, Guizhou 561113, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
  • China-Serbia "Belt and Road" Joint Laboratory for Natural Products and Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu-Chong-Zhi Road, Zhangjiang Hitech Park, Shanghai 201203, C…

ORCID-Profile: Ying Tian, Likun Gong

Förderung

  • High-level Innovative Research Institute of Department of Science and Technology of Guangdong Province
  • High-level Innovative Research Institute of the Department of Science and Technology of Guangdong Province

Zitieren

APA

Xu, J., Liu, P., Wu, Y., He, H., Hu, D., Sun, J., Chen, J., Tian, Y., & Gong, L. (2025). AHR Deficiency Exacerbates Hepatic Cholesterol Accumulation via Inhibiting Bile Acid Synthesis in MAFLD Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010349

Vancouver

Xu J, Liu P, Wu Y, He H, Hu D, Sun J, et al. AHR Deficiency Exacerbates Hepatic Cholesterol Accumulation via Inhibiting Bile Acid Synthesis in MAFLD Rats. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010349

BibTeX
@article{Xu2025,
  author = {Xu, Junjiu and Liu, Pengwei and Wu, Yuling and He, Hongxiu and Hu, Dandan and Sun, Jianhua and Chen, Jing and Tian, Ying and Gong, Likun},
  title = {AHR Deficiency Exacerbates Hepatic Cholesterol Accumulation via Inhibiting Bile Acid Synthesis in MAFLD Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010349}
}
Kostenlos starten →